StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/309% below fair value
$0.81−0.02 (-2.41%)

Close on Nov 19, 2026Market cap $35.87MP/E –Yield –

Elutia shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Elutia's shares outstanding was 44M at Jun 30, 2026. For fiscal 2025 it was 46M, up 58.0% from the year before. The highest annual figure on record is 46M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202546M+58.0%
FY2024Dec 31, 202429M+60.1%
FY2023Dec 31, 202318M+31.3%
FY2022Dec 31, 202214M+32.4%
FY2021Dec 31, 202110M+266.2%
FY2020Dec 31, 20203M+341.6%
FY2019Dec 31, 20191M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202644M-4.5%
Q1 FY2026Mar 31, 202643M+0.2%
Q4 FY2025Dec 31, 202547M+35.6%
Q3 FY2025Sep 30, 202547M+32.2%
Q2 FY2025Jun 30, 202546M+86.0%
Q1 FY2025Mar 31, 202543M+79.5%
Q4 FY2024Dec 31, 202435M+50.1%
Q3 FY2024Sep 30, 202436M+108.7%
Q2 FY2024Jun 30, 202425M+53.5%
Q1 FY2024Mar 31, 202424M+48.1%
Q4 FY2023Dec 31, 202323M+70.7%
Q3 FY2023Sep 30, 202317M+25.4%
Q2 FY2023Jun 30, 202316M+46.3%
Q1 FY2023Mar 31, 202316M+57.8%
Q2 FY2022Jun 30, 202214M+33.2%
Q1 FY2022Mar 31, 202214M+32.7%
Q4 FY2021Dec 31, 202111M+1610.1%
Q3 FY2021Sep 30, 202110M+1478.9%
Q2 FY2021Jun 30, 202110M+1477.8%
Q1 FY2021Mar 31, 202110M+1476.8%
Q3 FY2020Sep 30, 20201M+0.5%
Q2 FY2020Jun 30, 20201M–
Q1 FY2020Mar 31, 20201M–
Q4 FY2019Dec 31, 20191M–
Q3 FY2019Sep 30, 20191M–

More Elutia figures

See a number that looks wrong?